Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

PoC study results support efficacy of lonafarnib in patients with HDV

March 10, 2015

FDA approves Cresemba for invasive aspergillosis and invasive mucormycosis

March 9, 2015

Tekmira completes merger with OnCore to create hepatitis B solutions company

March 9, 2015

Phase III trial of VSV-EBOV for Ebola launching in Guinea

March 9, 2015

RQx Pharmaceuticals reports new peptide antibiotics

March 5, 2015

Roche discloses RSV fusion inhibitors

March 5, 2015

KU Leuven patents new antibiotics

March 5, 2015

Novel means of blocking Ebola entry into cells with existing agents identified

March 4, 2015

Prevenar 13 approved in E.U. for prevention of pneumococcal pneumonia in adults

March 4, 2015

New clinical trial evaluates ZMapp for Ebola virus

March 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...